EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY 4.0

Correction to “Clinical Significance of Albumin‐ and Bilirubin‐Based Biomarkers in Glaucoma: A Retrospective Case–Control Study”

Oxidative Medicine and Cellular Longevity · 2026-01 · 2026 (1)

DOI: 10.1155/omcl/9767860 ↗

Kurz gefasst

Korrektur in der Zeitschrift Oxidative Medicine and Cellular Longevity, online erschienen am 01.07.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “Clinical Significance of Albumin‐ and Bilirubin‐Based Biomarkers in Glaucoma: A Retrospective Case–Control Study”. Oxidative Medicine and Cellular Longevity, 2026(1). https://doi.org/10.1155/omcl/9767860

Vancouver

Correction to “Clinical Significance of Albumin‐ and Bilirubin‐Based Biomarkers in Glaucoma: A Retrospective Case–Control Study”. Oxidative Medicine and Cellular Longevity. 2026;2026(1). doi:10.1155/omcl/9767860

BibTeX
@article{euvimed2026,
  title = {Correction to “Clinical Significance of Albumin‐ and Bilirubin‐Based Biomarkers in Glaucoma: A Retrospective Case–Control Study”},
  journal = {Oxidative Medicine and Cellular Longevity},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/omcl/9767860}
}
Kostenlos starten →